POCT operators and clinicians are outside of laboratory medicine and most of them lack medical laboratory training but can contribute expertise and experience in other clinical areas and/or administrative and patient care duties. We consider that an interdisciplinary or multidisciplinary committee is essential for a successful POCT program.
Interdisciplinary Committee Does an interdisciplinary committee improve the quality of POCT?
#Abbott istat iqcp how to
Most importantly, this revision will review the current literature and provide guidance to the laboratory, to clinicians, and to operators in how to best adopt POCT in their setting to optimize patient care.
#Abbott istat iqcp update
Instead, this revision will provide an update on the latest peer literature since publication of the previous guideline and focus on several key aspects of POCT process and patient outcomes such as: A quality assurance program is vital to managing errors and the reliability of POCT results, and the intent of this guideline revision is not to debate the value or need for a quality management program. Instead this guideline will focus on how clinicians can get the most efficacy and highest quality results from implementing best practices for POCT. Therefore, this guideline revision will not focus on the various ways that POCT is utilized to support healthcare, nor focus on proving the value of POCT. POCT is currently routine in all hospitals and has become the standard for patient care in a variety of other health care settings. As manufacturers continue to introduce new POCT technologies, POCT is increasing in popularity, breadth of testing, and in the diversity of available clinical applications. POCT is a now proven approach that can provide faster turnaround (TAT) of laboratory test results. Tackling all areas needing revision would greatly delay publication of the revised guidelines hence the committee members felt that the highest priority for revision should address the “management of POCT.” Many of these areas have guidelines that are under revision by other organizations. The committee noted several areas of the previous guideline where there have been few additional publications over the past decade, such as transcutaneous bilirubin, intraoperative parathyroid hormone, and pH testing however, most areas in the previous guidelines have several recent publications including cardiac markers, coagulation, critical care, diabetes, drugs and ethanol, infectious disease, renal function, and reproductive testing. The American Association for Clinical Chemistry (AACC) Academy (formerly known as the National Academy of Clinical Biochemistry, NACB) formed a committee of experts on point-of-care testing (POCT) to revise the Laboratory Medicine Practice Guidelines (LMPG) Evidence-Based Practice for Point-of-Care Testing published in 2006 (1, 2). Saint Louis University School of Medicineĭirector Infectious Diseases, Scientific AffairsĪssistant Professor of Pathology, Microbiology, and Immunology Everett Chalmers Regional Hospital Horizon Health NetworkĪssociate Professor of Pathology and Pediatrics Medical Biochemist and Division Head, Clinical Chemistryĭr. Medical Director, Clinical Chemistry and Point-of-Care Testingĭepartment of Pathology and Laboratory Medicine Professor of Pathology, Microbiology, and Immunology Presentation title: Management of Point-of-Care Testing: An AACC Academy Guidance Document
The following video is a presentation on this Guidance Document, recorded during the virtual AACC Annual Scientific Meeting in December 2020.
0 kommentar(er)
